- Home
- CHCT vs ETON Comparison
CHCT vs ETON Comparison
Compare CHCT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHCT | ETON |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 411.9M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CHCT | ETON |
|---|---|---|
| Price | $16.08 | $18.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $18.00 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 357.3K | 285.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.83% | N/A |
| EPS Growth | ★ 134.78 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $121,195,000.00 | $39,011,000.00 |
| Revenue This Year | $9.06 | $107.23 |
| Revenue Next Year | $8.61 | $29.72 |
| P/E Ratio | $201.88 | ★ N/A |
| Revenue Growth | 4.67 | ★ 23.29 |
| 52 Week Low | $13.23 | $11.09 |
| 52 Week High | $18.90 | $23.00 |
Technical Indicators
Market Signals| Indicator | CHCT | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 64.96 |
| Support Level | $14.96 | $16.04 |
| Resistance Level | $17.34 | $20.01 |
| Average True Range (ATR) | 0.43 | 1.08 |
| MACD | -0.12 | 0.10 |
| Stochastic Oscillator | 9.15 | 70.56 |
Price Performance
Historical ComparisonAbout CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.